comparemela.com

Latest Breaking News On - Astrazeneca oxford university covid - Page 11 : comparemela.com

5 things to know before the stock market opens Wednesday

5 things to know before the stock market opens Wednesday CNBC 12/30/2020 Fred Imbert Here are the most important news, trends and analysis that investors need to start their trading day: McConnell blocks $2,000 stimulus checks U.S. confirms first case of the new Covid strain discovered in U.K. Bitcoin surges past $28,000 for the first time Stock futures rise as Wall Street tries to build on its strong 2020 gains Oxford-AstraZeneca vaccine approved for emergency use in the U.K.  1. McConnell blocks $2,000 stimulus checks © Provided by CNBC Senate Majority Leader Mitch McConnell (R-KY) speaks at a news conference with other Senate Republicans at the U.S. Capitol on December 15, 2020 in Washington, DC.

AstraZeneca s Covid-19 Vaccine Just Got U K Approval Why the Stock Market Shrugged

Dec. 30, 2020 8:00 am ET Order Reprints Print Article U.K. Prime Minister Boris Johnson with a vial of the AstraZeneca/Oxford University Covid-19 vaccine. (Photo by Paul Ellis - WPA Pool/Getty Images) Getty Images Text size AstraZeneca’s Covid-19 vaccine was approved by U.K. regulators Wednesday but the approval doesn’t look likely to change market skepticism about the company. The vaccine developed by AstraZeneca along with Oxford University became the second to be approved for distribution by the U.K. The news was greeted with muted enthusiasm by investors, who sent the share up a modest 0.1% in London trading.

Indigenous pneumococcal vaccine hits the market - The Hindu BusinessLine

Indigenous pneumococcal vaccine hits the market December 28, 2020 × As parts of the world roll-out the Covid-19 vaccine, India launched an indigenously developed pneumococcal vaccine that would be priced at a fraction of its competitors in the local market. The pneumococcal vaccine can now be accessible to more children across the country, Health Minister Dr Harsh Vardhan said, unlike earlier when it was dependent on products from international companies. Drug-majors Pfizer and GlaxoSmithKline presently sell the product in India. The indigenous vaccine from Serum Institute of India would be priced at half that of the existing ones sold in the country, said Adar Poonawalla, Chief Executive of the company. It would be priced at $3 for a dose, and involved three doses, he said. The vaccine development involved a collaboration of over eight years, along with PATH and the Bill and Melinda Gates Foundation, he said, adding that it was tailored to protect against 6A and 19A strains

Prominent Delhi hospital says it is ready for Covid immunisation

Prominent Delhi hospital says it is ready for Covid immunisation ​ By Ashish Srivastava ( IANS) | Published on ​ Wed, Dec 23 2020 23:51 IST | ​ 0 Views Prominent Delhi hospital says it is ready for Covid immunisation.. Image Source: IANS News New Delhi, Dec 23 : A prominent hospital in south Delhi is ready to store the bulk of Covid vaccines required to inoculate people as per the priority set by the Centre. The Hamdard Institute of Medical Sciences and Research (HIMSR) has readied approximately 30 deep refrigerators which could store the variants of vaccine candidates for Covid-19, waiting for emergency use authorisation, its Medical Superintendent, Dr Ajaz Mustafa, told IANS.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.